5th Virus Safety Workshop – Next-Gen Biosafety Conference

Full-Day Virus Safety & Biosafety Event · 23 April 2026 · Vienna, Austria

Theme 2026: Next-Gen Biosafety – Innovations, Insights & Industry Standards

This year’s theme — “Next-Gen Biosafety: Innovations, Insights, and Industry Standards”
brings together leading experts, regulators, and industry scientists for a focused
virus safety conference exploring the technologies and strategies shaping the future of
biosafety testing, NGS-based virus detection, ATMPs and vaccines.

Join us for a face-to-face full-day event that combines:

  • in-depth scientific presentations
  • real-world implementation case studies
  • high-value networking with peers from biologics, vaccines, ATMPs and plasma-derived products

About the Conference

The 5th Virus Safety Workshop is designed as a
single-day conference and networking event for professionals working in:

  • virus safety and biosafety testing
  • biopharmaceutical development and manufacturing
  • vaccines and ATMPs
  • regulatory affairs, quality and biosafety strategy

Across one intensive day in Vienna, you’ll receive
actionable insights, regulatory perspectives and
peer benchmarks you can directly apply in your own virus safety programs.

Event Highlights

Session 1: Regulatory Updates – Virus Safety & Biosafety Standards

Understand the latest developments in virus safety regulations and their impact on
biosafety strategies across the biopharmaceutical sector.
Learn how evolving guidelines influence study design, validation, and the use of new technologies
such as NGS and molecular methods.

Session 2: Next-Generation Sequencing (NGS) in Biosafety Testing

Discover how Next-Generation Sequencing (NGS) is transforming
pathogen detection and biosafety testing:

  • practical NGS case studies for adventitious agent detection
  • integration of NGS into virus safety strategies
  • lessons learned from early adopters implementing NGS under GMP

Get a clear view of where NGS can replace or complement traditional in vivo and in vitro assays.

Session 3: Platform Technologies & Continuous Manufacturing

Learn how platform technologies and continuous manufacturing are driving safer,
more efficient bioproduction:

  • platform-based virus safety strategies
  • process validation and viral clearance across multiple products
  • how modern biosafety concepts fit into lifecycle and platform approaches

This session is ideal for teams building platform processes or updating their virus safety
packages to meet current expectations.

Session 4: ATMPs and Vaccines – Virus Safety in Advanced Modalities

Explore virus safety challenges and best practices for
Advanced Therapy Medicinal Products (ATMPs) and vaccines:

  • virus safety strategies for gene and cell therapies
  • specific considerations for vaccine development and manufacturing
  • how to use tools like NGS and high-containment facilities to support innovative products

If you’re working in ATMPs, gene therapy or vaccines, this session will be especially relevant.

Featured Speakers & Experts

Gain insight from distinguished external speakers and ViruSure specialists, including:

  • Johannes Blümel (Paul-Ehrlich-Institut, PEI) – Leading authority on
    virus safety and regulatory science.
  • Martin Spruth (AGES – Austrian Agency for Health and Food Safety) – Expert from Austria’s
    national authority for health, food and pharmaceutical safety.
  • Thomas Kreil (Takeda) – Global expert in plasma-derived therapies and
    viral safety.
  • Clara Panosa (HIPRA) – Specialist in vaccine development and
    biological safety.
  • Andy Bailey (CEO, ViruSure) – Co-founder and industry leader in
    virus safety testing and biosafety strategy.
  • Hans-Peter Fasching (ViruSure) – Expert in
    Next-Generation Sequencing applications for biosafety and adventitious agent detection.

This mix of regulators, industry leaders and CRO specialists makes the
5th Virus Safety Workshop a uniquely practical virus safety conference for
decision-makers.

Why Attend This Virus Safety Conference in Vienna?

By joining this year’s full-day conference and workshop, you won’t just hear about next-gen
biosafety – you’ll see how it is implemented in real-world settings.

1. See what works in practice

Explore concrete implementation case studies and hear real lessons learned from early adopters
of NGS and next-gen biosafety technologies in GMP environments.

2. Stay ahead of regulators

Gain early insight into where the regulatory landscape is heading and what you can do now to
prepare for future virus safety and biosafety requirements.

3. Ask the questions that matter to you

Use this in-person conference to raise your own questions, challenges and needs directly with
regulators, technology leaders and industry strategists.

4. Build collaborations before you need them

Connect with peers from biologics, vaccines, ATMPs and plasma-derived products to spark future
projects, partnerships and collaborations.

5. Benchmark against the broader market

Compare your current virus safety strategy with peer and industry practice, and learn from
parallel industries also navigating evolving biosafety expectations.

6. Find smarter, faster paths to market

Identify practical ways to shorten timelines and see where
NGS and platform technologies can add efficiency and confidence to your own workflows.

7. Leave with concrete, ready-to-use takeaways

Go back to your organisation with peer-approved practices, frameworks and ideas you can apply
as soon as you’re back at your desk:

  • clearer view of virus safety options
  • updated understanding of regulatory expectations
  • new contacts for follow-up discussions and projects

What You’ll Take Home

By the end of this full-day virus safety conference and workshop in Vienna, you’ll have:

  • first-hand insight into evolving virus safety and biosafety standards
  • a clear view of the technologies reshaping virus safety testing, including NGS
  • practical ideas for integrating these approaches into your own programs
  • direct connections with the experts and peers actively shaping the future biosafety landscape

We look forward to welcoming you to Vienna for this
inspiring, knowledge-rich and highly interactive event — a full-day
virus safety and biosafety conference where the future of biosafety takes shape.

If you want, next step I can add a suggested H1 title tag + meta description + keyword list you can plug into Yoast/RankMath directly.

Register now Get the Agenda
 

Fees  |   Venue

 

The event is already open. Registration is now possible.

Fees

A symbolic fee of € 280 includes your attendance, coffee breaks, lunch, and a networking session with a special selection of Austrian wines.

Venue

Tech Gate Technology Tower
Donau-City-Straße 1

1220 Vienna

Austria

How to get there: Metro line 1 (U1) stop Kaisermühlen- Vienna International Center (VIC)

 

Recommended Hotels

Hotel NH Danube City

Wagramer Str. 21

1220 Vienna, Austria

Location: 5 min walking distance from the workshop venue

 

ARCOTEL Kaiserwasser Wien

Wagramer Str. 8

1220 Vienna, Austria

Location: 5 min walking distance from the workshop venue

 

District Living

Donau-City-Straße 3

1220 Vienna, Austria

Location: 5 min walking distance from the workshop venue

Register & payment

*(if the company is based outside of Europe or there is no VAT number then include NA)

Payment

Please carefully read our Terms & Conditions
* mandatory fields